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valvotomy in pulmonary atresia with intact ventricular septum and
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Mazeni Alwi, MRCP, Kok-Kuan Choo, MRCP, Nomee A. M. Radzi, MRCPCH, Hasri Samion, MD,
Kiew-Kong Pau, FRCS, and Chee-Chin Hew, FRCS, Kuala Lumpur, MalaysiaPMA total of 37 patients with pulmonary atresia with intact ventricular septum and intermediate right
ventricle underwent concomitant patent ductus arteriosus (PDA) stenting at the time of
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Doff B. McElhinney, MD, Gerald R. Marx, MD, Audrey C. Marshall, MD, John E. Mayer, MD, and
Pedro J. del Nido, MD, Boston, MassT/
B
SEIn patients with polysplenia and unilateral pulmonary arteriovenous malformations due to hepatic
venous flow-streaming after Fontan completion, cavopulmonary pathway reconfiguration with
hepatic vein-azygous vein connection improves hypoxemia, supporting the importance of hepatic
venous blood in the pathogenesis of pulmonary arteriovenous malformations and the practice of
Fontan revision in such patients.
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S112A The Journal of Thoracic an371 Surgical management of complete atrioventricular septal defect: Associations
with surgical technique, age, and trisomy 21(continued on page 14A
d Cardiovascular Surgery c June 2011Andrew M. Atz, MD, John A. Hawkins, MD, Minmin Lu, MS, Meryl S. Cohen, MD,
Steven D. Colan, MD, James Jaggers, MD, Ronald V. Lacro, MD, Brian W. McCrindle, MD, MPH,
Renee Margossian, MD, Ralph S. Mosca, MD, Lynn A. Sleeper, ScD, and L. LuAnnMinich, MD, for
the Pediatric Heart Network Investigators, Charleston, SC; Salt Lake City, Utah; Watertown and
Boston, Mass; Philadelphia, Pa; Durham, NC; Toronto, Ontario, Canada; and New York, NYMortality and morbidity are low after complete atrioventricular septal defect repair regardless of
surgical technique or presence of trisomy 21. Age at repair #2.5 months and concurrent surgical
procedures are not associated with residual defects or degree of left atrioventricular valve
regurgitation, but are associated with longer postoperative ventilator, intensive care unit, and total
hospital duration.1380 Totally thoracoscopic repair of atrial septal defect without robotic assistance:
A single-center experience
Zeng-Shan Ma, MD, PhD, Ming-Feng Dong, MD, Qiu-Yang Yin, MD, Zhi-Yu Feng, MD, and
Le-Xin Wang, MD, PhD, Liaocheng, Shandong, China, and Wagga Wagga, AustraliaForty patients (23 female patients; average age, 15.46 8.7 years) with secundum-type atrial septal
defects (ASDs) were selected for totally endoscopic repair of ASDs through small incisions on the
chest without robotic assistance. Through 3-port incisions in the right chest, pericardiotomy,
bicaval occlusion, atriotomy, and ASD repair were performed by a surgeon through
a thoracoscopy. The cardiopulmonary bypass and aortic crossclamp times were 56.2 6 21.1 and
38.3 6 8.6 minutes, respectively. The length of stay in the intensive care unit was 23.0 6 4.1
hours. There were no mortalities and no major complications in this cohort. Patients were
discharged from the hospital 4 to 6 days after the operation. Transesophageal echocardiographic
analysis immediately after the operation and at 30 days showed complete closure of the defect
without residual shunt. We conclude that totally endoscopic ASD repair can be achieved without
a robotically assisted surgical system. This technique is safe and effective and can be used as
a therapeutic option for ASD.General Thoracic
Surgery (GTS)
1384 Multicenter analysis of high-resolution computed tomography and positron
emission tomography/computed tomography findings to choose therapeutic
strategies for clinical stage IA lung adenocarcinoma
Morihito Okada, MD, PhD, Haruhiko Nakayama, MD, PhD, Sakae Okumura, MD, PhD,
Hiromitsu Daisaki, PhD, Shuji Adachi, MD, PhD, Masahiro Yoshimura, MD, PhD, and
Yoshihiro Miyata, MD, PhD, Hiroshima, Yokohama, Tokyo, and Akashi, JapanThis multicenter study using a phantom study to correct inter-institutional variability of PET/CT
findings shows that maxSUV is a significant preoperative predictor for surgical outcomes. HRCT
and PET/CT findings are important to select therapeutic strategies for treating clinical stage IA
adenocarcinoma of the lung, such as sublobar resection.1392 Impact of neoadjuvant chemoradiotherapy followed by surgical resection on
node-negative T3 and T4 non–small cell lung cancer
Benedict D. T. Daly, MD, Michael I. Ebright, MD, Allan J. Walkey, MD, Hiran C. Fernando, MBBS,
Ken S. Zaner, MD, PhD, Donna M. Morelli, BS, and Lisa A. Kachnic, MD, Boston, MassPatients with invasive node-negative T3 and T4 non–small cell lung cancer receiving concurrent
chemoradiotherapy before surgical resection have significantly improved survival.)











S114A The Journal of Thoracic an398 Sternal dehiscence in patients with moderate and severe chronic obstructive
pulmonary disease undergoing cardiac surgery: The value of supportive thorax
vests(continued on page 16A)
d Cardiovascular Surgery c June 2011Sezai Celik, MD, Ahmet Kirbas, MD, Onur Gurer, MD, Yahya Yildiz, MD, and Omer Isik, MD,
Istanbul, TurkeyThe effect of moderate and severe COPD on the development of sternal dehiscence and the use of
the Robicsek technique for sternal closure along with a sternal support vest postoperatively in the
incidence of sternal dehiscence were evaluated in patients with moderate and severe COPD
undergoing cardiac surgery.1403 Ten-year experience with the muscle split technique, bioabsorbable plates, and
postoperative bracing for correction of pectus carinatum: The Innsbruck
protocol
Barbara Del Frari, MD, and Anton H. Schwabegger, MD, MSc, Innsbruck, AustriaThe combination of the muscle split technique and absorbable osteosynthesis is an option in
thoracoplastic repair of pectus carinatum. Postoperative bracing is furthermore an important
adjunct in the successful treatment of these patients with respect to the final aesthetic outcome.Acquired Cardiovascular
Disease (ACD)
1410 Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical
heart valves
Stephen H. McKellar, MD, MSc, Stuart Abel, BS, Christopher L. Camp, MD,
Rakesh M. Suri, MD, DPhil, Mark H. Ereth, MD, and Hartzell V. Schaff, MD, Rochester, MinnMechanical valve prostheses necessitate lifelong anticoagulation. Warfarin has limitations,
including 1% to 2% per year stroke incidence. Dabigatran etexilate does not have warfarin’s
limitations but has not been tested in this setting. Positive preclinical data show that dabigatran
etexilate may provide an alternative to warfarin for patients with mechanical valves.1417 Open arch reconstruction in the endovascular era: Analysis of 721 patients
over 17 years
Himanshu J. Patel, MD, Christopher Nguyen, BS, Amy C. Diener, RN, BSN,
Mary C. Passow, RN, BSN, Diane Salata, RN, BSN, and G. Michael Deeb, MD,
Ann Arbor, MichWe present results with open aortic arch reconstruction over a 17-year period, reflecting the results
in the endovascular era. These data may be suitable for comparison and suggest that certain
subgroups, including those with advanced age or impaired renal function, may be ideal candidates
for emerging endovascular options.1424 Impact of pulmonary hypertension on outcomes after aortic valve replacement
for aortic valve stenosis
Spencer J. Melby, MD, Marc R. Moon, MD, Brian R. Lindman, MD, Marci S. Bailey, RN, MSN,
Laureen L. Hill, MD, and Ralph J. Damiano, Jr, MD, St Louis, MoPulmonary hypertension (PH) is common among patients undergoing AVR for stenosis. Patients
undergoing AVR with PH had increased operative mortality and decreased long-term survival, and
those with persistent PH fared worst. Because PH has an adverse affect on outcomes, it should be
considered in preoperative risk assessment.











S116A The Journal of Thoracic an431 Tricuspid annuloplasty prevents right ventricular dilatation and progression of
tricuspid regurgitation in patients with tricuspid annular dilatation
undergoing mitral valve repair(continued on page 18A
d Cardiovascular Surgery c June 2011Nico R. Van de Veire, MD, PhD, Jerry Braun, MD, Victoria Delgado, MD,
Michel I. M. Versteegh, MD, Robert A. Dion, MD, PhD, Robert J. M. Klautz, MD, PhD, and
Jeroen J. Bax, MD, PhD, Leiden, The NetherlandsIn patients with a dilated tricuspid annulus undergoing mitral valve repair without concomitant
tricuspid valve annuloplasty, echocardiographic outcome was worse at the 2-year follow-up. In
contrast, patients with tricuspid annular dilatation undergoing concomitant mitral valve repair and
tricuspid valve annuloplasty demonstrated reverse right ventricular remodeling and reduction of
tricuspid regurgitation.1440 TheMosaic porcine bioprosthesis: Role of age on clinical performance in aortic
position
Friedrich-Christian Rieß, MD, Ralf Bader, MD, Eva Cramer, MD, Lorenz Hansen, MD,
Sandra Schiffelers, J€urgen Wallrath, and Gunter Wahl, MD, Hamburg, Germany, and
Maastricht, The NetherlandsWe examined the performance of the Mosaic bioprosthesis in patients 65 years of age or less and
patients older than 65 years. In both groups similar hemodynamic performance was found. In the
younger patients the incidence of structural valve disease, endocarditis, valve-related reoperation,
and explantation is higher, and the incidence of structural valve deterioration is similar or lower.1449 St Jude Medical Epic porcine bioprosthesis: Results of the regulatory
evaluation
W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P. Sakwa, MD, Denton A. Cooley, MD,
Vibhu R. Kshettry, MD, Kent W. Jones, MD, Tirone E. David, MD, John A. Sullivan, MD,
Guy J. Fradet, MD, and David S. Bach, MD, Vancouver, British Columbia, Toronto, Ontario, and
Halifax, Nova Scotia, Canada; Sarasota, Fla; Royal Oak and Ann Arbor, Mich; Houston, Tex;
Minneapolis, Minn; and Salt Lake City, UtahThe St Jude Medical Epic tricomposite glutaraldehyde-preserved porcine bioprosthesis was
implanted in 761 patients in the US Food and Drug Administration regulatory study in 22
investigational centers.The actuarial freedom from SVD was satisfactory at 4 years. There were 2
cases of AVR perforation without calcification. There were no MVR cases of SVD.1455 Up to 6-year follow-up after pulmonary vein isolation for persistent/permanent
atrial fibrillation: Importance of sinus node function
Yoshiharu Soga, MD, PhD, Hitoshi Okabayashi, MD, PhD, Yoshio Arai, MD, PhD,
Takuya Nomoto, MD, PhD, Jota Nakano, MD, Takehiko Matsuo, MD, and
Michiya Hanyu, MD, PhD, Ikoma, Morioka, and Kitakyushu, JapanThe cure rate of persistent/permanent AF after pulmonary vein isolation was significantly poorer in
patients with sinus node dysfunction than in patients with normal sinus node function. Cut-and-sew
pulmonary vein isolation may be an adequate treatment for persistent/permanent AF in patients
with normal sinus node function.)











S118A The Journal of Thoracic an461 Less invasive versus conventional double-valve surgery: A propensity-matched
comparison(continued on page 20A)
d Cardiovascular Surgery c June 2011Fernando A. Atik, MD, Lars G. Svensson, MD, PhD, FACC, Eugene H. Blackstone, MD, FACC,
A. Marc Gillinov, MD, FACC, Jeevanantham Rajeswaran, MSc, and Bruce W. Lytle, MD, FACC,
Cleveland, OhioLess invasive approaches to double-valve surgery are increasingly used for improved cosmesis;
however, few studies investigate their effect on outcome. We compared these less invasive
approaches with full sternotomy using propensity matching and found that less invasive approaches
had blood-use advantages and no apparent detriments.Perioperative
Management (PM)
1469 Administration of recombinant activated factor VII in the intensive care unit
after complex cardiovascular surgery: Clinical and economic outcomes
Walter E. Uber, PharmD, John M. Toole, MD, Martha R. Stroud, MS, Jason S. Haney, PharmD,
John Lazarchick, MD, Fred A. Crawford, Jr, MD, and John S. Ikonomidis, MD, PhD,
Charleston, SCRecombinant activated factor VII administration to patients in the intensive care unit appears to be
comparable with reoperation for refractory bleeding after complex cardiovascular surgical
procedures and might be considered as an alternative to reoperation in selected patients. Future
prospective, randomized controlled trials are needed to clearly validate these findings.1478 Landiolol hydrochloride for prevention of atrial fibrillation after coronary
artery bypass grafting: New evidence from the PASCAL trial
Akira Sezai, MD, PhD, Kazutomo Minami, MD, PhD, Toshiko Nakai, MD, PhD,
Mitsumasa Hata, MD, PhD, Isamu Yoshitake, MD, PhD, Shinji Wakui, MD, PhD,
Motomi Shiono, MD, PhD, and Atsushi Hirayama, MD, PhD, Tokyo, JapanPostoperative atrial fibrillation was reduced by treatment with landiolol hydrochloride, an ultrashort-
acting beta-blocker. Amelioration of ischemia, an anti-inflammatory effect, and inhibition of
sympathetic hypertonia by landiolol presumably reduced the occurrence of atrial fibrillation.1488 Cardiopulmonary bypass in malignant hyperthermia susceptible patients:
A systematic review of published cases
Thomas Metterlein, MD, Wolfgang Zink, MD, Eva Kranke, RN, Assad Haneya, MD,
Bernhard Graf, MSc, MD, and Peter Kranke, MD, Regensburg and W€urzburg, GermanyMalignant hyperthermia is a potentially lethal complication of general anesthesia. Symptoms of
malignant hyperthermia may be obscured during cardiopulmonary bypass. A systematic search was
conducted to identify signs that allow an early appropriate diagnosis. Further, treatment and
prophylaxis of malignant hyperthermia during cardiac surgery are discussed.1496 Changes in cysteinyl leukotrienes during and after cardiac surgery with
cardiopulmonary bypass in patients with and without chronic obstructive
pulmonary disease
Nicolas de Prost, MD, PhD, Claudine El-Karak, MD, Maria Avila, MD,
Fumito Ichinose, MD, PhD, and Marcos F. Vidal Melo, MD, PhD, Boston, MassDuring and after cardiac surgery with cardiopulmonary bypass, patients with chronic obstructive
pulmonary disease had larger airway resistances, deeper hypoxemia, and longer-lasting
postoperative mechanical ventilation than those without chronic obstructive pulmonary disease.
Urinary cysteinyl leukotriene concentrations increased with time in both groups, but more in
patients with chronic obstructive pulmonary disease.













120A The Journal of Thoracic an503 Interaction between neoplastic cells and cancer-associated fibroblasts through
the CXCL12/CXCR4 axis: Role in non–small cell lung cancer tumor
proliferation(continued on page 22A)
d Cardiovascular Surgery c June 2011Ori Wald, MD, PhD, Uzi Izhar, MD, Gail Amir, MD, Sophie Kirshberg, BSc, Zippora Shlomai, MSc,
Gideon Zamir, MD, Amnon Peled, PhD, and Oz M. Shapira, MD, Jerusalem, IsraelFindings suggest that the interaction between cancer-associated fibroblasts and tumor epithelial
cells via the CXCL12/CXCR4 axis play a role in non–small cell lung cancer tumor proliferation
and mark the CXCL12/CXCR4 axis as a target for immune intervention in treating this entity.1513 Calcification of allograft and stentless xenograft valves for right ventricular
outflow tract reconstruction: An experimental study in adolescent sheep
Willem Flameng, MD, PhD, Ramadan Jashari, MD, Geofrey De Visscher, PhD,
Lindsay Mesure, MSc, and Bart Meuris, MD, PhD, Leuven and Brussels, BelgiumThis experimental study shows the superiority of pulmonary homografts over aortic homografts for
right ventricular outflow tract reconstruction. Stentless porcine xenografts and bovine jugular vein
conduits are an acceptable alternative because they have low cusp calcification and no leaflet
tearing or cusp immobilization. However, significant wall calcification develops despite any
anticalcification treatment.1522 An artificial nanoemulsion carrying paclitaxel decreases the transplant heart
vascular disease: A study in a rabbit graft model
Domingos D. Lourenc¸o-Filho, MD, PhD, Raul C. Maranh~ao, MD, PhD,
Carlos A. Mendez-Contreras, MD, Elaine R. Tavares, BSci, Fatima R. Freitas, PhD, and
Noedir A. Stolf, MD, PhD, S~ao Paulo, BrazilEleven rabbits with heart grafts were treated with paclitaxel associated with a cholesterol-rich
nanoemulsion (LDE) in addition to cyclosporin A. Compared with 10 grafted control animals,
rabbits receiving LDE–paclitaxel treatment showed a 50% reduction in stenosis in grafted hearts,
whereas the arterial lumen was 3-fold larger than in control hearts. Macrophage infiltration in grafts
decreased 7-fold.1529 Controlled hyperkalemic reperfusion with magnesium rescues ischemic
juvenile hearts by reducing calcium loading
Hajime Imura, MD, Hua Lin, MSc, Elinor J. Griffiths, PhD, and
M.-Saadeh Suleiman, PhD, DSc, Tokyo, Japan, and Bristol, United KingdomJuvenile guinea-pig hearts were subjected to ischemia and controlled hyperkalemic reperfusion
without or with different concentrations of Mg21 without intervention during ischemia. Elevated
Mg21 rescued the heart even when hyperkalemia alone was not protective. Studies on myocytes
showed this was likely due to reducing [Ca21]i, which aids metabolic recovery.Cardiothoracic
Imaging
1538 Apicoaortic conduit in a patient with severe aortic stenosis: An alternative to
transcutaneous aortic valve implantation
Sotiris C. Stamou, MD, and Nicholas T. Kouchoukos, MD, St Louis, Mo1539 High-resolution computed tomography with three-dimensional reconstruction
for assessment of chronic pulmonary thromboembolic disease
Thoralf M. Sundt, MD, and Eric E. Williamson, MD, Rochester, Minn
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d Cardiovascular Surgery c June 2011Stephan Jacobs, MD, PhD, Michael Gessat, PhD, Thomas Walther, MD, PhD, and
Volkmar Falk, MD, PhD, Z€urich, Switzerland, and Bad Nauheim, Germany1543 Anterior arch translocation for coarctation of circumflex aorta using median
sternotomy without cardiopulmonary bypass
Krishnan Ganapathy Subramaniam, MCh, Kulasekharan Marimuthu, MCh,
Krishna Manohar, MCh, Sudeep Verma, MD, and Kotturathu Mammen Cherian, FRACS,
Chennai, India1545 Successful thoracoscopic surgery for intractable pneumothorax after
pneumonectomy under local and epidural anesthesia
Masafumi Noda, MD, Yoshinori Okada, MD, Sumiko Maeda, MD, and
Takashi Kondo, MD, Sendai, Japan1547 Arterial switch operation in children with interrupted aortic arch: Long-term
outcomes
Tyson A. Fricke, BMedSci, Christian Brizard, MS, MD, Yves d’Udekem, MD, PhD, and
Igor E. Konstantinov, MD, PhD, Melbourne, AustraliaBrief Research Report 1549 Rat model of cardiopulmonary bypass for deep hypothermic circulatory arrest
Tom Waterbury, MPS, CCP, LP, Thomas J. Clark, BS, Scott Niles, BS, and
Robert Saeid Farivar, MD, PhD, Iowa City, IowaOnline Only: Brief
Clinical Reports
e39 Congenital tracheal stenosis caused by a new tracheal ring malformation
Juan L. Anton-Pacheco, MD, PhD, Marıa Lopez, MD, Cecilia Moreno, MD, and
Gerardo Bustos, MD, PhD, Madrid, Spaine41 Expanding cardiac pseudotumor
Krishna Bhagwat, MCh, Jane Hallam, MBBS, Gangahanumaiah Shivanand, MCh,
Mathew Brooks, MD, Victoria Atkinson, MD, FRACS, and John Goldblatt, MD, FRACS,
Parkville, Victoria, Australiae43 Tracheoesophageal fistula due tomigration of a self-expanding esophageal stent
successfully treated with a silicone ‘‘Y’’ tracheobronchial stent
Jose Melendez, MD, Danny Chu, MD, Faisal G. Bakaeen, MD, and Roberto F. Casal, MD,
Houston, Texe45 Annulus-edge-papillary stitch to repair P2 of the mitral valve posterior leaflet
Samer Kassem, MD, and Majed Othman, MD, Milan, Italy, and Damascus, Syriae48 First experience with a paracorporeal artificial lung in a small child with
pulmonary hypertension
Avihu Z. Gazit, MD, Stuart C. Sweet, MD, R. Mark Grady, MD, and
Charles B. Huddleston, MD, St Louis, Mo
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